These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15708524)

  • 1. Patient heal thyself.
    Benson RS
    Drug Discov Today; 2005 Feb; 10(3):159-61. PubMed ID: 15708524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 3. [Now no new drugs will be developed!].
    Lafolie P
    Lakartidningen; 2006 Jan 25-31; 103(4):225. PubMed ID: 16491556
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost of therapy.
    Somberg JC
    Am J Ther; 2000 Nov; 7(6):343-4. PubMed ID: 11304640
    [No Abstract]   [Full Text] [Related]  

  • 5. Bigger isn't always better.
    Nature; 2002 Jul; 418(6896):353. PubMed ID: 12140518
    [No Abstract]   [Full Text] [Related]  

  • 6. Brand-name drug companies fail to meet R&D commitments.
    Kondro W
    CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891
    [No Abstract]   [Full Text] [Related]  

  • 7. Downward pressure on US drug prices if Kerry wins.
    Andrawiss M
    Drug Discov Today; 2004 Oct; 9(20):861. PubMed ID: 15475314
    [No Abstract]   [Full Text] [Related]  

  • 8. The price of pills. Does it really take $897 million for a new therapy?
    Ezzell C
    Sci Am; 2003 Jul; 289(1):25. PubMed ID: 12840941
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost of new drugs.
    Goozner M
    Health Aff (Millwood); 2005; 24(3):883-4; author reply 884-5. PubMed ID: 15886185
    [No Abstract]   [Full Text] [Related]  

  • 10. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 11. Will R&D make Merck hot again?
    Simons J
    Fortune; 2002 Jul; 146(1):89-90, 92, 94. PubMed ID: 12119729
    [No Abstract]   [Full Text] [Related]  

  • 12. Centers for education and research in therapeutics.
    Woosley RL
    Clin Pharmacol Ther; 1994 Mar; 55(3):249-55. PubMed ID: 8143390
    [No Abstract]   [Full Text] [Related]  

  • 13. Goliath befriends David.
    Clarke T; Pearson H
    Nature; 2001 Nov; 414(6863):482-3. PubMed ID: 11734817
    [No Abstract]   [Full Text] [Related]  

  • 14. World CAB. Focus on international drug pricing.
    GMHC Treat Issues; 2004; 18(1-2):8-13. PubMed ID: 15119275
    [No Abstract]   [Full Text] [Related]  

  • 15. Daniel Vasella.
    Hughes B
    Nat Rev Drug Discov; 2010 Feb; 9(2):98. PubMed ID: 20118958
    [No Abstract]   [Full Text] [Related]  

  • 16. $1 billion R&D spender emerges.
    Ward M
    Nature; 1995 Aug; 376(6542):626. PubMed ID: 7651500
    [No Abstract]   [Full Text] [Related]  

  • 17. Merck-Medco merger boosts druggists' anger about pricing levels.
    Scott L
    Mod Healthc; 1993 Nov; 23(48):16. PubMed ID: 10130120
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a market for personal medicine?
    Sherrid P
    US News World Rep; 2003 Jan; 134(2):56. PubMed ID: 12561698
    [No Abstract]   [Full Text] [Related]  

  • 19. Abbott Laboratories' pricing malfunction.
    Salyer D
    Surviv News (Atlanta Ga); 2004; 15(3):18-9. PubMed ID: 15218860
    [No Abstract]   [Full Text] [Related]  

  • 20. Are drug too expensive in Canada? No.
    Williams R; Marion J
    Can Fam Physician; 2006 May; 52():573-6, 578-81. PubMed ID: 16739822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.